Stock Based Compensation (Tables)

12 Months Ended

Dec. 31, 2019

Share-based Payment Arrangement [Abstract]

Schedule of stock-based compensation expense stock options and restricted stock

	Year Ended		Period from January 24, 2018 (inception) to
	December 31, 2019		December 31, 2018
Research and development	$	—	$	—
General and administrative		590,041		1,329,074
	$	590,041	$	1,329,074

Schedule of fair value of employee stock options

	Year Ended December 31, 2019			Year Ended December 31, 2018
Weighted average exercise price	$	4.42		$	2.50
Weighted average grant date fair value	$	3.08		$	1.21
Assumptions
Expected volatility		88-90	%		92.24	%
Weighted average expected term (in years)		6.3			6.26
Risk-free interest rate		1.68-2.31	%		2.93	%
Expected dividend yield		0.00	%		0.00	%

Schedule of stock option activity

	Number of Shares		Weighted- Average Exercise Prices		Weighted- Average Remaining Contractual Term (In Years)		Intrinsic Value
Outstanding at January 1, 2018		—	$	—		—	$	—
Granted		1,073,082		2.50		—		—
Outstanding at December 31, 2018		1,073,082		2.50		9.64	$	—
Granted		1,065,996		4.42		—		—
Outstanding at December 31, 2019		2,139,078	$	3.46		9.17	$	4,052,512
Exercisable at December 31, 2019		470,000	$	2.62		8.71	$	1,283,560